Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

NCT01051219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: Losartan

Sponsor

Newcastle-upon-Tyne Hospitals NHS Trust

Collaborators

[object Object]